Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

December 31, 2031

Study Completion Date

December 31, 2031

Conditions
Amyotrophic Lateral SclerosisMovement DisordersDegenerative DisorderMotor Neuron Disease
Trial Locations (12)

10032

RECRUITING

Columbia University, New York

20007

RECRUITING

Georgetown University, Georgetown

32224

RECRUITING

Mayo Clinic, Jacksonville

60611

RECRUITING

Northwestern University, Chicago

63110

RECRUITING

Washington University, St Louis

77030

RECRUITING

Baylor College of Medicine, Houston

85013

RECRUITING

Barrow Neurological Institute, Phoenix

92121

RECRUITING

University of California San Diego, San Diego

98195

RECRUITING

University of Washington, Seattle

02114

RECRUITING

Massachusetts General Hospital, Boston

Unknown

RECRUITING

Instituto Roosevelt, Bogotá

00935

RECRUITING

CHALS-CCT UPR MScience, San Juan

All Listed Sponsors
lead

Target ALS Foundation, Inc.

OTHER